Funder: Crohn's and Colitis Foundation
Due Dates (Anticipated): August 2026: Request Therapeutics Incubator collaboration agreement for redline by applicant's institution deadline (projected) | October 2026: Full proposal submission deadline (including redlined agreement) (projected)
Funding Amounts: Up to $1,500,000 over 3 years per project; most funds support CRO-based research, with some available for academic partners.
Summary: Supports academic teams in developing novel, validated drug targets for Crohn’s disease and ulcerative colitis through collaborative preclinical drug discovery.